← All Veracyte, INC filings

Veracyte, INC Form 4 insider transactions

NASDAQ
VCYT
Veracyte, INC
Form 4: Veracyte Executive Phillip G. Febbo Reports Acquisition of Restricted Stock Units
Phillip G. Febbo, Chief Scientific & Medical Officer of Veracyte, Inc., reports the acquisition of restricted stock units and a disposition of common stock on March 6, 2024.
NASDAQ
VCYT
Veracyte, INC
Form 4: Veracyte SVP, General Counsel Annie McGuire Reports Changes in Beneficial Ownership
Annie McGuire, SVP, General Counsel of Veracyte, Inc., reports the withholding of shares to cover tax obligations related to the vesting of Restricted Stock Units.
NASDAQ
VCYT
Veracyte, INC
Form 4: Veracyte VP Jonathan Wygant Reports Stock Transactions
Jonathan Wygant, VP and Chief Accounting Officer of Veracyte, Inc., reports the withholding of shares to cover tax obligations related to vesting restricted stock units.
NASDAQ
VCYT
Veracyte, INC
Form 4: Veracyte Director Evan Jones Exercises Options and Sells Shares
Director Evan Jones exercised stock options and sold 10,000 shares of Veracyte (VCYT) common stock on March 1, 2024.
NASDAQ
VCYT
Veracyte, INC
Form 4: Veracyte CFO Rebecca Chambers Reports Tax Withholding Transaction
Rebecca Chambers, CFO of Veracyte, Inc., reports the withholding of common stock to cover tax obligations related to the vesting of Restricted Stock Units.
NASDAQ
VCYT
Veracyte, INC
Form 4: Veracyte Executive John Leite Reports Stock Transaction
John Leite, Chief Commercial Officer-CLIA of Veracyte, Inc., reports the withholding of shares to cover tax obligations related to vesting restricted stock units.
NASDAQ
VCYT
Veracyte, INC
Form 4: Veracyte CEO Marc Stapley Reports Stock Transactions
CEO Marc Stapley reports the withholding of Veracyte common stock to cover tax obligations related to vesting restricted stock units, along with stock purchases through the employee stock purchase plan.